방사성 의약품 : 기술과 세계 시장

The global radiopharmaceuticals market is expected to grow from $10.3 billion in 2024 and is projected to reach $21.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 16.4% during the forecast period of 2024 to 2029.

The North American radiopharmaceuticals market is expected to grow from $4.9 billion in 2024 and is projected to reach $11.5 billion by the end of 2029, at a CAGR of 18.5% during the forecast period of 2024 to 2029.

The European radiopharmaceuticals market is expected to grow from $2.3 billion in 2024 and is projected to reach $4.9 billion by the end of 2029, at a CAGR of 16.4% during the forecast period of 2024 to 2029.

Report Scope

This report analyzes the global market for radiopharmaceuticals, in terms of quantitative and qualitative data, to help readers understand the market, to assess business/growth strategies, and to make informed business decisions regarding radiopharmaceuticals. BCC Research estimates market data for 2023 (the base year) and 2024 and forecasts values for 2025 through 2029. The radiopharmaceuticals market segmentation is based on product, application, production method, countries and regions.

Drivers, restraints and opportunities in the radiopharmaceuticals market are also discussed. The report also describes the competitive landscape of the radiopharmaceuticals market and highlights emerging trends. The latest new products, acquisitions, and collaborations related to the radiopharmaceuticals market are also covered.

Report Includes

• 50 data tables and 68 additional tables
• Analyses of trends in the global market for radiopharmaceuticals, with revenue data for 2021 to 2023, estimates for 2024, and projected CAGRs through 2029
• Estimates of the size, and revenue prospects for, the global market, along with a market share analysis by product type, application, production method, and region/country
• Facts and figures pertaining to the market dynamics, technological progress, regulations, prospects, innovations and the impact of various macroeconomic factors
• Insights derived from the Porter's Five Forces model, as well as global supply/value chain and PESTLE analyses
• An analysis of patents, clinical trials, emerging trends and other developments in the industry
• Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
• Analysis of the industry structure, including companies' market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
• Profiles of leading companies, including Cardinal Health, Lantheus, Curium, GE Healthcare, and Novartis AG

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Radiopharmaceuticals Overview
• Preparation of Radiopharmaceuticals
• Macroeconomic Factors Analysis
• Porter's Five Forces Analysis
• Threat of New Entrants (Moderate to Low)
• Threat of Substitutes (Low to Moderate)
• Bargaining Power of Suppliers (High)
• Bargaining Power of Buyers (Moderate)
• Industry Rivalry (Moderate)

Chapter 3 Market Dynamics

• Market Drivers
• Rising Prevalence of Cancer and Other Chronic Diseases
• Unmet Need in Oncology
• Precision Medicine
• Nuclear Imaging Technologies
• Increasing Investment
• Market Restraints
• Manufacturing and Supply Chain Issues
• Infrastructure and Specialized Imaging Equipment Requirements
• Shortage of Skilled Professionals
• Market Trends
• Theranostics
• Regional Diversification and Supply Chain Resilience
• Opportunities
• Radiopharmaceuticals Contract Manufacturing
• PET Imaging in AD

Chapter 4 Regulatory Landscape

• U.S.
• European Union
• Japan

Chapter 5 Emerging Technologies and Developments

• Emerging Technologies
• Ac-225 and Pb-212
• Nanoparticle-based Theranostic Agents
• Clinical Trials Analysis
• Diagnostic Radiopharmaceuticals
• Therapeutic Radiopharmaceuticals
• Patent Analysis
• Key Takeaways

Chapter 6 Market Segmentation Analysis

• Segmentation Breakdown
• Radiopharmaceuticals Market, by Product Type
• Diagnostic Radiopharmaceuticals
• Diagnostic Radiopharmaceuticals Market, by Imaging Technique Type
• Diagnostic Radiopharmaceuticals Market, by Production Method
• Therapeutic Radiopharmaceuticals
• Therapeutic Radiopharmaceuticals Market, by Product Type
• Radiopharmaceuticals Market by Application
• Market Overview
• Oncology
• Cardiology
• Neurology
• Others
• Radiopharmaceuticals Market by Radioisotope Production Method
• Market Overview
• Market Revenue and Forecast
• Geographic Breakdown
• Radiopharmaceuticals Market Breakdown by Region
• North America
• Europe
• Asia-Pacific
• RoW

Chapter 7 Competitive Intelligence

• Overview
• Diagnostic Radiopharmaceuticals
• Therapeutic Radiopharmaceuticals

Chapter 8 Sustainability in Radiopharmaceuticals Market: ESG Perspective

• Role of ESG in the Radiopharmaceuticals Industry
• Environment
• Social
• Governance
• ESG Risk Ratings
• Conclusion

Chapter 9 Appendix

• Methodology
• Sources
• Abbreviations
• Company Profiles
• BAYER AG
• BLUE EARTH DIAGNOSTICS
• BOSTON SCIENTIFIC CORP.
• BWXT MEDICAL LTD.
• CARDINAL HEALTH
• CURIUM
• ECKERT & ZIEGLER
• GE HEALTHCARE
• INTERNATIONAL ISOTOPES INC.
• IONETIX CORP.
• JUBILANT PHARMOVA LTD.
• LANTHEUS
• NMR
• NOVARTIS AG
• SIEMENS HEATHNIEERS AG
• Emerging Start-ups/Market Disruptors